SCHEMBL7401222

SCHEMBL7401222

Fc1ccc2c(c1)CCOC2CCCl

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 17/20 0.43
SLC6A4 P31645 6/20 0.43
HTR1A P08908 4/20 0.43
DRD2 P14416 2/20 0.43
ADRA1D P25100 2/20 0.43
ADRA1A P35348 2/20 0.43
ADRA1B P35368 2/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
DRD1 P21728 1/20 0.43
DRD4 P21917 1/20 0.43
HTR2A P28223 1/20 0.43
DRD3 P35462 1/20 0.43
HTR2B P41595 1/20 0.43
HTR1B P28222 12/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7401152 0.85 HTR1D (0.46) HTR1DSLC6A4HTR1ADRD2ADRA1D
SCHEMBL7402369 0.83 HTR1D (0.39) HTR1DHTR1ADRD2ADRA1DADRA1A
SCHEMBL19824779 0.82 HTR1D (0.42) HTR1DSLC6A4HTR1ADRD2ADRA1D
SCHEMBL11225184 0.82 ESR1 (0.43) HTR1DHTR1ADRD2DRD1DRD4
SCHEMBL19813069 0.81 DRD1 (0.49) HTR1DSLC6A4HTR1ADRD2ADRA1D
SCHEMBL19813070 0.81 DRD1 (0.49) HTR1DSLC6A4HTR1ADRD2ADRA1D
SCHEMBL19812820 0.78 TAAR1 (0.55) HTR1DSLC6A4HTR1ADRD2ADRA1D
SCHEMBL19812818 0.78 TAAR1 (0.55) HTR1DSLC6A4HTR1ADRD2ADRA1D
SCHEMBL19813091 0.78 TAAR1 (0.55) HTR1DSLC6A4HTR1ADRD2ADRA1D
SCHEMBL7402123 0.78 DRD2 (0.50) HTR1DHTR1ADRD2ADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6133446-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 2000-10-17 US disclosed
EP-0737189-B1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS UPJOHN CO (US) 1999-07-28 EP disclosed
US-5877317-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 1999-03-02 US disclosed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP disclosed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO disclosed